NOTCH1 signaling promotes human iPSC-to-PGCLC-like differentiation
- 1Center of Reproductive Medicine, The Affiliated Children’s Hospital of Shanxi Medical University, Taiyuan, PR China; Center of Reproductive Medicine, Children’s Hospital of Shanxi, Shanxi Women and Children Health Hospital, Taiyuan, PR China
Abstract
Background: Research into human infertility is limited by incomplete knowledge of germline specification and the absence of reproducible human models for investigating signaling pathways. This study examines whether NOTCH signaling, particularly the DLL4–NOTCH1 axis, contributes to PGCLC-like differentiation from human induced pluripotent stem cells (iPSCs). Methods: A single commercially purchased human iPSC line was subjected to staged PGCLC-like induction, with sampling at D0, D3, and D7. Temporal pathway activity and lineage status were assessed using RT-qPCR (pluripotency genes and NOTCH1 targets), immunoblotting (NICD, HES1, and HEY1), and flow cytometry (CD38 and intracellular DDX4). Pathway involvement was examined by continuous DLL4 stimulation, γ-secretase inhibition with DAPT, and siRNA-mediated NOTCH1 knockdown. Results: NOTCH pathway readouts were highest at the earliest sampled differentiation point (D3) and remained above D0 at D7, coinciding with reduced pluripotency markers and increased PGCLC-associated markers. Pharmacological activation with DLL4 increased pathway readouts and the frequency of CD38+/DDX4+ cells, whereas γ-secretase inhibition with DAPT reduced both. At D7, the representative CD38+/DDX4+ fractions were 7.45% in control cells, 19.1% with DLL4, and 3.21% with DAPT. NOTCH1 knockdown attenuated pathway activity and PGCLC-associated readouts. In the NOTCH1-silenced background, DLL4 restored the measured readouts toward baseline but did not reproduce the enhancement observed with intact NOTCH1, a pattern consistent with a substantial contribution of NOTCH1 while not excluding residual NOTCH1 activity or other NOTCH receptors. In the genetic series, representative CD38+/DDX4+ fractions were 8.39% for si-NC, 0.642% for si-NOTCH1, and 7.98% for DLL4 plus si-NOTCH1. Conclusion: NOTCH pathway readouts peaked at D3 and remained elevated at D7, while DLL4 stimulation, DAPT inhibition, and NOTCH1 knockdown produced directionally consistent changes in PGCLC-associated readouts. These findings support a contribution of sustained NOTCH signaling and NOTCH1 to PGCLC-like differentiation.
Related
- Curcumin promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the miR-206/Hdac4 signaling axis
- Tceal7 is a BRG1-regulated target of calcineurin signaling that promotes myoblast differentiation
- RBFOX2 Autoregulation Promotes Cardiomyocyte Transcriptome Maturation and Differentiation
- METTL14 Promotes Chicken Preadipocyte Differentiation by Modulating mRNA Stability via a Dual-Reader m⁶A Mechanism.
- The small ORF (smORF)-encoded polypeptide MIRINE promotes neuronal differentiation in vertebrate brain development
BibTeX
@article{su2026notch1,
title = {{NOTCH1 signaling promotes human iPSC-to-PGCLC-like differentiation}},
author = {Dan Su and Xiaoling Li and Xingyu Bi and Pengfei Zhu and Junmei Fan and Xueqing Wu},
journal = {Journal of Radiation Research and Applied Sciences},
year = {2026},
month = nov,
doi = {10.1016/j.jrras.2026.102720},
url = {https://doi.org/10.1016/j.jrras.2026.102720},
note = {CC BY},
}
RIS
TY - JOUR
TI - NOTCH1 signaling promotes human iPSC-to-PGCLC-like differentiation
AU - Dan Su
AU - Xiaoling Li
AU - Xingyu Bi
AU - Pengfei Zhu
AU - Junmei Fan
AU - Xueqing Wu
PY - 2026
DA - 2026/11/02
JO - Journal of Radiation Research and Applied Sciences
DO - 10.1016/j.jrras.2026.102720
UR - https://doi.org/10.1016/j.jrras.2026.102720
AB - Background: Research into human infertility is limited by incomplete knowledge of germline specification and the absence of reproducible human models for investigating signaling pathways. This study examines whether NOTCH signaling, particularly the DLL4–NOTCH1 axis, contributes to PGCLC-like differentiation from human induced pluripotent stem cells (iPSCs). Methods: A single commercially purchased human iPSC line was subjected to staged PGCLC-like induction, with sampling at D0, D3, and D7. Temporal pathway activity and lineage status were assessed using RT-qPCR (pluripotency genes and NOTCH1 targets), immunoblotting (NICD, HES1, and HEY1), and flow cytometry (CD38 and intracellular DDX4). Pathway involvement was examined by continuous DLL4 stimulation, γ-secretase inhibition with DAPT, and siRNA-mediated NOTCH1 knockdown. Results: NOTCH pathway readouts were highest at the earliest sampled differentiation point (D3) and remained above D0 at D7, coinciding with reduced pluripotency markers and increased PGCLC-associated markers. Pharmacological activation with DLL4 increased pathway readouts and the frequency of CD38+/DDX4+ cells, whereas γ-secretase inhibition with DAPT reduced both. At D7, the representative CD38+/DDX4+ fractions were 7.45% in control cells, 19.1% with DLL4, and 3.21% with DAPT. NOTCH1 knockdown attenuated pathway activity and PGCLC-associated readouts. In the NOTCH1-silenced background, DLL4 restored the measured readouts toward baseline but did not reproduce the enhancement observed with intact NOTCH1, a pattern consistent with a substantial contribution of NOTCH1 while not excluding residual NOTCH1 activity or other NOTCH receptors. In the genetic series, representative CD38+/DDX4+ fractions were 8.39% for si-NC, 0.642% for si-NOTCH1, and 7.98% for DLL4 plus si-NOTCH1. Conclusion: NOTCH pathway readouts peaked at D3 and remained elevated at D7, while DLL4 stimulation, DAPT inhibition, and NOTCH1 knockdown produced directionally consistent changes in PGCLC-associated readouts. These findings support a contribution of sustained NOTCH signaling and NOTCH1 to PGCLC-like differentiation.
SN - 2314-7164
SN - 1687-8507
ER -